Atlantic Union Bankshares’s AstraZeneca AZN Stock Holding History

Atlantic Union Bankshares’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.98M	Sell	25,273 -23,796	-48%	-$4.59M	0.1%	191
2025 Q4	$9.02M	Buy	49,069 +405	+0.8%	+$71K	0.17%	126
2025 Q3	$7.47M	Buy	48,664 +336	+0.7%	+$50.9K	0.14%	147
2025 Q2	$6.75M	Buy	48,328 +46,228	+2,201%	+$6.48M	0.15%	134
2025 Q1	$309K	Sell	2,100 -190	-8%	-$27.5K	0.02%	258
2024 Q4	$300K	Sell	2,290 -18	-0.8%	-$2.52K	0.02%	266
2024 Q3	$360K	Hold	2,308	–	–	0.02%	259
2024 Q2	$360K	Buy	+2,308	New	+$347K	0.02%	261
2014 Q2	–	Sell	-167	Closed	-$9K	–	129
2014 Q1	$9K	Buy	+167	New	+$10.8K	﹤0.01%	204

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Atlantic Union Bankshares's AZN Position: Q1 2026 in Review

Atlantic Union Bankshares reduced its AstraZeneca (AZN) stake by 48% in Q1 2026, selling an estimated $4.59M and leaving 25,273 shares worth $4.98M. The position accounts for 0.1% of the portfolio, ranked #191.

Atlantic Union Bankshares first reported a position in AZN in Q1 2014 and has held it in 9 quarters since. The position peaked at $9.02M in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Atlantic Union Bankshares held 25,273 shares of AstraZeneca worth $4.98M as of Q1 2026.
Atlantic Union Bankshares sold 23,796 AstraZeneca shares in Q1 2026, an estimated $4.59M.
AstraZeneca made up 0.1% of Atlantic Union Bankshares's portfolio in Q1 2026, its #191 holding.
Atlantic Union Bankshares first reported a position in AstraZeneca in Q1 2014 and has held it in 9 quarters since.
Atlantic Union Bankshares's AstraZeneca position peaked at $9.02M in Q4 2025.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.